LIPOCINE INC.
Patent Owner
Stats
- 20 US PATENTS IN FORCE
- 20 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 20 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 8,161 Total Citation Count
- Feb 26, 1999 Earliest Filing
- 44 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0319,596 METHODS FOR IMPROVING QUALITY OF LIFE OR SEXUAL DOMAIN FUNCTION AND COMPOSITION USEFUL IN THE METHODSNov 10, 16Nov 09, 17[A61K]
2017/0246,187 (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USEAug 28, 15Aug 31, 17[A61K, C07J]
2017/0035,781 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODSJun 22, 16Feb 09, 17[A61K]
2017/0020,893 LIPOBALANCED LONG CHAIN TESTOSTERONE PRODRUGS FOR ORAL DELIVERYApr 26, 16Jan 26, 17[A61K]
2017/0007,623 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODSSep 15, 16Jan 12, 17[A61K]
2016/0213,686 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODSApr 05, 16Jul 28, 16[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9399069 17-Hydroxyprogesterone ester containing oral compositions and related methodsFeb 27, 15Jul 26, 16[A61K, A61Q]
9364547 17-hydroxyprogesterone ester containing oral compositions and related methodsApr 24, 14Jun 14, 16[A61K, A61Q]
9358298 17-hydroxyprogesterone ester containing oral compositions and related methodsSep 04, 14Jun 07, 16[A61K, A61Q]
9358299 17-hydroxyprogesterone ester-containing oral compositions and related methodsJul 16, 15Jun 07, 16[A61K, A61Q]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0367,569 HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONSAbandonedAug 14, 15Dec 22, 16[A61K]
2016/0361,322 COMPOSITION AND METHOD FOR ORAL DELIVERY OF ANDROGEN PRODRUGSAbandonedJun 15, 16Dec 15, 16[A61J, A61K, B65D]
2016/0193,225 (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USEAbandonedAug 31, 15Jul 07, 16[A61K]
2016/0193,228 LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERYAbandonedFeb 04, 16Jul 07, 16[A61K]
2016/0030,583 PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASEAbandonedMay 11, 15Feb 04, 16[A61K]
2016/0015,649 PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGSAbandonedJun 05, 15Jan 21, 16[A61K]
2015/0374,826 PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGSAbandonedSep 08, 15Dec 31, 15[A61K]
2015/0320,765 HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONSAbandonedJul 16, 15Nov 12, 15[A61K]
2015/0224,130 Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical CompositionsAbandonedAug 14, 14Aug 13, 15[A61K]
2015/0064,243 PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMININISTRATION OF HYDROPHOBIC DRUGSAbandonedNov 07, 14Mar 05, 15[A61K]
2014/0323,453 LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERYAbandonedJun 30, 14Oct 30, 14[A61K]
2014/0309,202 HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONSAbandonedJun 06, 14Oct 16, 14[A61K]
2014/0303,132 LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERYAbandonedMay 30, 14Oct 09, 14[A61K]
2014/0288,039 LIPOBALANCED LONG CHAIN TESTOSTERONE PRODRUGS FOR ORAL DELIVERYAbandonedMay 30, 14Sep 25, 14[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
